Decoy Therapeutics is trading at $2.76, up 5.34%, with no confirmed company-specific catalyst.
- Scheduled to present at an investor conference on September 10, following events beginning September 9.
- Available coverage reports no clear catalyst for the September 9 premarket rise.
- Broader U.S. indexes were modestly lower, so market sentiment does not explain the gain.